财务数据和关键指标变化 - 公司在第二季度报告了7.4百万美元的经营亏损,与去年同期的6.8百万美元相比有所增加,主要是由于加快了商业化举措 [29] - 公司在本期的现金消耗为7.9百万美元,略高于前六个季度的平均水平,主要是由于某些推迟发布和FDA提交成本以及其他时间因素 [30] - 公司在本期通过公开发行筹集了920万美元的毛额资金,或810万美元的净额 [30] - 截至2023年6月30日,公司拥有14.5百万美元的现金和现金等价物,总资产为17.6百万美元 [30] 各条业务线数据和关键指标变化 - 公司正在开发一款名为EV的智能戒指产品,该产品针对女性设计,具有医疗级别的功能和FDA认证 [8][9][10] - EV戒指可以测量心率、血氧饱和度、皮肤温度、睡眠阶段和时长、心率变异性、呼吸率、卡路里消耗、步数和活跃时间等关键健康指标 [13][14] - 公司已经完成了首次510(k)申请提交,正在等待FDA的审查和批准 [10] 各个市场数据和关键指标变化 - 公司正在与多家潜在合作伙伴进行合作,包括一家全球运动服装公司、一家大型健康保险公司和一家领先的远程患者监测公司 [12] - 公司正在与更多的医疗保健和消费者企业进行对话,探讨各种合作和商业机会 [13] 公司战略和发展方向及行业竞争 - 公司正在开发自有的单芯片射频解决方案,作为无袖血压和无创血糖监测的基础技术 [26][27] - 公司已经完成了首次血压临床试验,并计划进行后续试验以进一步优化原型和算法 [27] - 公司正在优化天线和电路板布局,以提高血糖监测的信号灵敏度,并计划进行后续的临床试验 [27] - 公司认为EV戒指的推出正值女性健康和赋权的大趋势,具有良好的市场机会 [28] 管理层对经营环境和未来前景的评论 - 公司推迟了EV戒指的发布时间,主要是为了增加一个更精确的传感器组件,以提高在小手指和低灌注情况下的数据采集能力 [37][38][39] - 公司相信这一延迟将有助于交付一款高质量的产品,并为媒体和影响者提供更多的评估时间 [39] - 公司对于最终获得FDA批准持谨慎乐观态度,并表示即使未获批准也可以作为一款健康设备推出 [10] - 公司认为FDA批准可能会成为未来与医疗保健和其他企业达成商业协议的催化剂 [10] 问答环节重要的提问和回答 问题1 **为什么推迟了发布时间?** **回答** 公司希望增加一个更精确的传感器组件,以提高在小手指和低灌注情况下的数据采集能力。这将有助于交付一款高质量的产品,并为媒体和影响者提供更多的评估时间。[37][38][39] 问题2 **你如何确保能够按时完成新的发布时间?** **回答** 公司已经完成了FDA申报所需的所有测试和文件准备工作。公司一直在持续推进营销、生产准备、客户服务等工作。公司已经测试了新的传感器组件,并确认其性能有所提升。公司相信这不会影响最终产品的表现。[41][42][43] 问题3 **新的发布时间是否会影响利用节假日销售的机会?** **回答** 公司认为,EV戒指的整体发布计划远远超出了第四季度。公司看到了社会对女性健康的关注度越来越高,相信这是一个很好的时机推出这样的产品。公司相信目前积累的市场热情将转化为节假日和之后的销售。[44]

Investor Presentation August 2023 FORWARD LOOKING STATEMENTS This presentation has been prepared by Movano Inc. (“we,” “us,” “our,” “Movano” or the “Company”) and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 82-4233771 (State of incorporation) (I.R.S. Employer Identification No. ) 6800 K ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 26-0579295 (State of incorporation) (I.R.S. Employer Identification No. ) 6800 ...

Movano Inc. (NASDAQ:MOVE) Q1 2023 Earnings Conference Call May 15, 2023 12:00 PM ET Company Participants J. Cogan ??? Chief Financial Officer John Mastrototaro ??? Chief Executive Officer Tyla Bucher ??? Chief Marketing Officer Stacy Salvi ??? Vice President of Strategy Michael Leabman ??? Founder and Chief Technology Officer Conference Call Participants Operator Greetings, and welcome to Movano???s First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-an ...

Investor Presentation May 2023 Forward Looking Statements This presentation has been prepared by Movano Inc. ("we," "us," "our," "Movano" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or j ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission file number: 001-40254 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 82-4233771 (State of incorporatio ...

Movano Inc. (NASDAQ:MOVE) Q4 2022 Earnings Conference Call March 20, 2023 12:00 PM ET Company Participants J. Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Tyla Bucher - Chief Marketing Officer Michael Leabman - Founder and Chief Technology Officer Stacy Salvi - Vice President of Strategy Conference Call Participants Bruce Jackson - The Benchmark Company Operator Hello, and welcome to Movano Health Fourth Quarter 2022 Earnings Call. I would like to remind everybody that this ca ...